Below is the text of the page https://www.bayer.com/en/berocca.aspx stored 2016-08-06 by archive.org.ua. The original page over time could change. View as original html

All About Berocca™ - Bayer

[/en/homepage.aspx] Menu Contact Share Search DE Home About Bayer About Bayer Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Overview Overview Profile and Organization Focus on Life Sciences Societal Needs Mission & Values Bayer Employees Bayer Worldwide Procurement Corporate Compliance Corporate Governance Political Involvement History Board of Management Supervisory Board Calendar Innovation Innovation Bayer is an innovation company with a more than 150-year history. Our scientific successes are intended to help improve people’s lives. Overview Overview Science For A Better Life Tour Research at Bayer Bayer Lifescience Center Open Innovation research – The Bayer Scientific Magazine Inventive Talent Otto Bayer Medal Products Products With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition. Overview Overview Product Areas Service Areas Information for Patients Beware of Counterfeits Report an Adverse Side-Effect Products from A to Z Sustainability Sustainability Read more about our economic, ecological and social challenges and opportunities. Overview Overview Strategy Focus Issues Management and Governance Supplier Management Employees Product Stewardship Safety Environmental Protection Social Commitment Report Ratings, Rankings and Awards Media Media This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group. Overview Overview News Biographies Board of Management Werner Baumann Johannes Dietsch Dr. Hartmut Klusik Kemal Malik Dieter Weinand Erica Mann Liam Condon Supervisory Board Werner Wenning Oliver Zühlke Speeches Photos TV Footage Publications Overview Integrated Annual Reports Quarterly Reports Bayer Magazine BEENOW Magazine Farming’s Future Magazine research Magazine technology solutions Magazine From Molecules to Medicine From Molecules to Veterinary Medicines Brochure Integrated Weed Management Names | Figures | Facts Transfers of Value to Physicians Brochure Videos Social Media Social Media Room Social Media Channels Apps Events Background Information Aspirin Bepanthen Berocca Thrombosis The Bayer Cross E-Cards Media Contact Investors Investors We want to create value for our shareholders through innovation, growth and high earning power. Overview Overview Bayer Group About Bayer Key Figures Profile and Organization Subsidiaries Acquisitions and Divestitures Our Products Markets and Economic Outlook Research & Development Bayer@Social Media Brochure Names Figures Facts Mission & Values Strategic Alignment Group Strategy Strategies of the Segments Value Management Forecast and Targets Opportunity and Risk Report Corporate Governance Articles of Incorporation Board of Management Supervisory Board Sustainability and Commitment Stock New Investor Listing and Key Figures Basic Data Key Figures Share Listings Equity Indices ADR Program Share Price Current Share Price Charts Closing Prices Dividends Profitability Analysts Analysts' Ratings Consensus Stockholders' Portal Ownership Structure Overview Voting Rights Announcements Archive Voting Rights Announcements Stock Programs Overview Aspire Participation Program Stock History Glossary Archive Bonds Overview Financial Strategy Financial Management Liability Mix Maturity Profile Net Financial Debt Credit Default Swaps Funding Instruments Overview Debt Issuance Programme Commercial Paper Programme Syndicated Loan Facility Bonds Issued Rating Bond News Credit Analysts Credit Relations Reports Annual Reports Overview Key Figures Comparison Financial Position Income Statement Cashflow Statement Segment Overview Region Overview Five-Year Summary Quarterly Reports Bayer AG Financial Statements Sustainability Reports Archive Annual Stockholders’ Meeting 2016 Events Calendar Live Events Q2 2016 Conference Call Bayer Offers to Acquire Monsanto Q1 2016 Conference Call FY/Q4 2015 Conference Call Investor Conferences Stockholders' Meeting Overview ASM 2015 ASM 2014 ASM 2013 ASM 2012 ASM 2011 ASM 2010 ASM 2009 ASM 2008 ASM 2007 ASM 2006 ASM 2005 Extraordinary ASM 2004 ASM 2004 ASM 2003 ASM 2002 Press Conferences Roadshows Other Presentations Archive 2015 Overview Q3 2015 Conference Call Finerenone Data at ESC Congress 2015 Q2 2015 Conference Call Meet Management 2015 NY Q1 2015 Conference Call Meet Management 2015 in Berlin FY/Q4 2014 Conference Call 2014 Overview Q3 2014 Conference Call Meet Management 2014 LDN Conference Call 2014-09-18 Planned Demerger MaterialScience Q2 2014 Conference Call Meet Management 2014 NY Conference Call 2014-05-06 Acquisition CC Business Merck Q1 2014 Conference Call Meet Management 2014 LEV FY/Q4 2013 Conference Call 2013 Overview Q3 2013 Conference Call Meet Management 2013 LDN Q2 2013 Conference Call Meet Management 2013 NY Q1 2013 Conference Call Meet Management 2013 LEV FY/Q4 2012 Conference Call 2012 Overview Meet Management in Tokyo Q3 2012 Conference Call Riociguat Data at CHEST 2012 Q2 2012 Conference Call Meet Management 2012 NY Q1 2012 Conference Call Conference Call ACC 2012 Meet Management 2012 LEV FY/Q4 2011 Conference Call Regorafenib Data at ASCO-GI 2011 Overview China Investor Conference Rivaroxaban Data at AHA 2011 Q3 2011 Conference Call Q2 2011 Conference Call Q1 2011 Conference Call Rivaroxaban Data at ACC 2011 FY/Q4 2010 Conference Call 2010 Overview Q3 2010 Conference Call Rivaroxaban Data at ESC 2010 Q2 2010 Conference Call Q1 2010 Conference Call FY/Q4 2009 Conference Call 2009 Overview Rivaroxaban Data at ASH 2009 Q3 2009 Conference Call Q2 2009 Conference Call Riociguat Data at ATS 2009 Q1 2009 Conference Call FY/Q4 2008 Conference Call 2008 Overview Rivaroxaban Data at AHA 2008 Q3 2008 Conference Call Q2 2008 Conference Call Rivaroxaban Data at EFORT 2008 Q1 2008 Conference Call FY/Q4 2007 Conference Call 2007 Overview Rivaroxaban Data at ASH 2007 Q3 2007 Conference Call Q2 2007 Conference Call HealthCare Investor Day 2007 Nexavar Data at ASCO 2007 Q1 2007 Conference Call FY/Q4 2006 Conference Call 2006 Overview Nexavar Melanoma Conference Call Q3 2006 Conference Call Rivaroxaban Conference Call Q2 2006 Conference Call Q1 2006 Conference Call FY/Q4 2005 Conference Call 2005 Overview Bayer R&D Investor Day 2005 Q3 2005 Conference Call CSFB Chemical Hybrid Tour 2005 CropScience Analyst & Investor Days Q2 2005 Conference Call Data on BAY 59-7939 at ISTH 2005 Sorafenib Data at ASCO 2005 Q1 2005 Conference Call Spring Investor Conference 2005 2004 Overview Fall Investor Conference 2004 BAY 43-9006 Data at EORTC Symposium CSFB Field Trip on September 22, 2004 1H 2004 Investor Conference BAY 43-9006 Data at ASCO 2004 Q1 2004 Conference Call Spring Investor Conference 2004 2003 Overview CSFB Field Trip on November 21, 2003 Fall Investor Conference 2003 Conference Call on Ad-hoc message Nov 7, 2003 Q1 2003 Conference Call Spring Investor Conference 2003 2002 Overview Spring Investor Conference 2002 Half Year Investor Conference 2002 Spring Investor Conference 2002 Spring Financial News Conference 2002 2001 Overview Fall Investor Conference 2001 Investor Conference Call on the Acquisition of Aventis CropScience News Conference Call: Acquisition of Aventis CropScience Half Year Investor Conference 2001 Spring Investor Conference 2001 Spring Financial News Conference 2001 2000 Overview Fall Investor Conference 2000 Investor Conference New York Spring Investor Conference 2000 Spring Press Conference 2000 1999 Ad-hoc Publications Latest Ad-hoc Announcements Archive Overview Ad-hoc 2015 Ad-hoc 2014 Ad-hoc 2013 Ad-hoc 2012 Ad-hoc 2011 Ad-hoc 2010 Ad-hoc 2009 Ad-hoc 2008 Ad-hoc 2007 Ad-hoc 2006 Ad-hoc 2005 Ad-hoc 2004 Ad-hoc 2003 Ad-hoc 2002 Ad-hoc 2001 Ad-hoc 2000 Ad-hoc 1999 Ad-hoc 1998 News Investor News Press Archive Overview Investor News 2015 Investor News 2014 Investor News 2013 Investor News 2012 Investor News 2011 Investor News 2010 Investor News 2009 Investor News 2008 Investor News 2007 Investor News 2006 Investor News 2005 Investor News 2004 Investor News 2003 Investor News 2002 Investor News 2001 Investor News 2000 Handouts Investor Handout Investor Factsheet Presentations Archive Investor Handouts Archive Presentations Downloads Current Downloads 2013-2015 2015 2014 2013 2008-2012 2012 2011 2010 2009 2008 2003-2007 2007 2006 2005 2004 2003 1998-2002 2002 2001 2000 1999 1998 Service Contact IR Team Order Publications Newsletter RSS Newsfeeds RSS Help Page Podcasts Mobile Services SMS-Service Collected Documents New on this site FAQs Investor Factsheet Career Career Looking for a job in an innovative company? Learn more about Bayer and the opportunities available. Overview Overview Why Bayer Overview Innovation & Solutions Development & Teamwork Better Life & Challenges Reputation & Impact Benefits & Rewards Values & Stories Overview David against Goliath Singapore's Supertrees Sky-high vegetables Bringing light into darkness Rice for a hungry planet Working at Bayer Overview Students Graduates Overview International Trainee Program for Financial Management International HR Trainee Program International Trainee Program for Production Management Future Leadership Program for Pharmacists in Product Supply Global Trainee Program for Supply Chain Management Procurement Trainee Program International Trainee Program for Engineers Professionals Bayer Career Worldwide How to join us Overview How to apply The Interview Video Center Contact us Magazine Search Our Businesses Locations Websites Contact us Home Media Background Information Berocca Print Share Berocca™ – The Healthy Edge for Sustained Performance Overview News Biographies Board of Management Werner Baumann Johannes Dietsch Dr. Hartmut Klusik Kemal Malik Dieter Weinand Erica Mann Liam Condon Supervisory Board Werner Wenning Oliver Zühlke Speeches Photos TV Footage Publications Overview Integrated Annual Reports Quarterly Reports Bayer Magazine BEENOW Magazine Farming’s Future Magazine research Magazine technology solutions Magazine From Molecules to Medicine From Molecules to Veterinary Medicines Brochure Integrated Weed Management Names | Figures | Facts Transfers of Value to Physicians Brochure Videos Social Media Social Media Room Social Media Channels Apps Events Background Information Aspirin Bepanthen Berocca Thrombosis The Bayer Cross E-Cards Media Contact Vitamins are essential components in an array of body functions such as energy metabolism, immune defense, or neuronal processing. A deficiency in vitamins and minerals can lead to serious diseases. Berocca™ has a specific formula which combines the water-soluble vitamins of the B complex, vitamin C, as well as the minerals calcium, magnesium, and zinc. All these vitamins and minerals are known to be important players in cognitive function. They act synergistically and provide consumers with the necessary edge to be on top of their game and to perform better. Consuming a broad variety of healthy food such as fruits and vegetables is the key for physical and mental well-being. With a modern, demanding and stressful life, dietary supplements have become an integral part of an overall wellness regimen and provide specific benefits for an optimized performance. As vitamins cannot be produced by the human body, they are mainly obtained through food. Vitamins are essential components in an array of body functions such as energy metabolism, immune defense, or neuronal processing. A deficiency in vitamins and minerals can lead to serious diseases. Ever since researchers discovered the vital function of vitamins and minerals, scientists have begun isolating these components to use them as food supplements. The first vitamins were produced at the beginning of the 20th century, however, only at small scales. In 1933, Swiss chemist Tadeusz Reichstein synthesized vitamin C at an industrial level for the first time. Throughout the next fifteen years, scientists all around the world reported successful synthesis of various vitamins of the B complex at industrial scales. These discoveries opened the door to multi-vitamin supplementation. zoom Supplementation with multi-vitamin and mineral combinations, such as Berocca™, help promote good health. These and other photos related to Berocca™ you can download here . Early on, one of the leading suppliers of various vitamin supplements was Roche Consumer Health. The Swiss company, which Bayer acquired in 2005, introduced Beflavin Roche (vitamin B1 and B2) and Benerva (vitamin B1) in the 1930’s. By the end of the decade, vitamin products became the mainstay of the company. Supplementing with water-soluble B vitamins has beneficial health effects. B vitamins cannot be stored in the body over longer periods of time. Therefore the body needs to be constantly supplied with sufficient amounts of these vitamins. There are a total of nine water-soluble vitamins: B1 (thiamine), B2 (riboflavin), B3 (niacin/nicotinamide), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), B12 (cobalamine), as well as vitamin C. All of them are specifically involved in cognitive function and energy metabolism. In 1969, Berocca™ was introduced in Switzerland as a neurotropic vitamin combination of the vitamin B complex plus vitamin C. Over the course of the next years, researchers realized that minerals were also necessary to support the function of vitamins in the body. This marked the beginning of the development of multi-vitamin and mineral combinations. With performance becoming more and more important in our society, holistic alternatives to products such as energy drinks were needed. In 2010, Bayer introduced a new version of Berocca™ with additional guarana. Berocca™ Boost is specially formulated to improve performance rapidly. Today, the Berocca™ formula is one of the rare vitamin and mineral supplements being supported by multiple double-blind, randomized and placebo-controlled clinical trials. Since 2004, the brand has been consecutively voted by Boots customers in the UK as “Best Energy Supplement”. Berocca™ is currently registered in about 70 countries, with more than 350 million packs sold worldwide. Historical Roadmap 1933 Synthesis of vitamin C 1936 Synthesis of vitamin B1 Synthesis of vitamin C 1940 Synthesis of vitamin B3 1944 Synthesis of vitamin B5 1945 Synthesis of vitamin B6 1946 Synthesis of vitamin B9 1969 Launch of Berocca™ (contains vitamin C and B complex) 1970 Berocca™ now contains calcium 1972 Synthesis of vitamin B12 1989 Berocca™ now contains magnesium 1998 Berocca™ now contains zinc 2000 Clinical trial on stress management is published 2008 Launch of Berocca™ Boost 2010 Clinical trial on improvement of physical and mental performance published 2011 Clinical trial on improvement of physical and mental performance published 2013 Clinical trial about performance through brain mapping The Story of Berocca™ Historical Milestones Consumer Benefits Scientific Background Scientific Studies Scientific Rationale Global Formula Consumer Benefits Physical stamina and mental sharpness both are important for achievement-driven individuals to perform. By leading a healthy lifestyle with sports and balanced nutrition, they can remain a step ahead, even when they have many professional and personal responsibilities to tackle. However, consuming adequate amounts of fruits and vegetables that deliver all the vitamins and minerals the body needs can become challenging. This is why many consumers then turn to micronutrient supplements like Berocca™. It contains all water-soluble vitamins of the B complex and C, as well as the minerals calcium magnesium and zinc. All these micronutrients are known to play an important role in energy metabolism and cognitive function. They act synergistically and provide consumers with the necessary edge to be on top of their game and to perform better. To date, only a few studies have assessed the relationship between supplementation with nutritional products and brain function. Berocca™ is among the few supplements with extensive scientific evidence. 1,2,3,4,5 All its micronutrients are known to be involved in cognitive function and energy metabolism, thus being effective against physical and mental strain. In these situations, the body storage for vitamins and minerals depletes more quickly. A subclinical deficiency may arise, causing symptoms such as fatigue or diminished concentration. Ideally, individuals can counteract these symptoms by consuming more fruits and vegetables. In a fast-paced world, however, micronutrient supplements are a convenient way to reap health and mental benefits. Many multi-vitamin supplements often only target cognitive performance alone. As physical stamina and mental sharpness are highly inter-related, Berocca™ has been developed to fill the dietary gap by using a formula that is specifically tailored to improve both neuronal and neuromuscular function. The combination provides superior efficacy in contrast to food that has been fortified with single vitamins or minerals. Berocca™ Boost contains guarana in addition to the micronutrients included in Berocca™ Performance. Supplementation with Berocca™ Boost was shown to lead to immediate improvements in cognitive performance and reduced mental fatigue. It is a healthy and natural alternative to products aimed at giving an energy boost. For sustained results, Berocca™ is recommended to be taken regularly. Because of its high safety profile, Berocca™ can be consumed even over a longer period of time. 1 Willemsem G, Petchot-Bacque JP, Alleaume B et al. A double-blind, placebo-controlled study of the effects of an oral multivitamin combination with calcium and magnesium on psychological well-being and cardiovascular reactions to stress in healthy young male volunteers. Eur J Clin Res 1997;9:175-184. 2 Caroll D, Ring C, Suter M et al. The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: a double-blind placebo-controlled trial. Psychopharmacology (Berl) 2000;150(2):220-225. 3 Schlebusch L, Bosch BA, Polglase G et al. A double-blind placebo-controlled, double-center study of the effects of an oral multivitamin-mineral combination on stress. S Afr Med J 2000;90(12):1216-1223. 4 Kennedy DO, Veasey R, Watson A et al. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology (Berl) 2010;211(1):55-68. 5 Kennedy DO, Veasey RC, Watson AW et al. Vitamins and psychological functioning: a mobile phone assessment of the effects of a B vitamin complex, vitamin C and minerals on cognitive performance and subjective mood and energy. Hum Psychopharmacol 2011;26(4-5):338-347. General information Berocca™ Global Country Websites Berocca™ Argentina Berocca™ Finland Berocca™ Denmaark Berocca™ Germany Berocca™ Norway Berocca™ Singapore Berocca™ South Africa Berocca™ Spain Berocca™ Sweden Berocca™ Switzerland Berocca™ UK Berocca™ USA Social Media Berocca™ on Youtube Berocca™ on Facebook International Organizations International Union of Nutritional Sciences World Health Organization Further Information European tolerable upper intake levels for vitamins and minerals Dietary reference intake table Vitamins | The Nutrition Source by Harvard School of Public Health Media Contact Patrick Kaiser Phone: +41 58 272-7616 patrick f8ffe15d87d446ba8c1ba12a2725294a . kaiser @ 8e660aa5bee14be5a1368f62c47f3d92 bayer . com Follow Us Facebook Twitter YouTube LinkedIn Instagram RSS Last updated: March 7, 2016 Copyright © Bayer AG Print Share Contact us Top http://www.bayer.com Conditions of Use Privacy Statement Imprint Technical Details Contact us Sitemap Deutsch About Bayer Profile and Organization Focus on Life Sciences Societal Needs Mission & Values Bayer Employees Bayer Worldwide Procurement Corporate Compliance Corporate Governance Political Involvement History Board of Management Supervisory Board Calendar Innovation Science For A Better Life Tour Research at Bayer Bayer Lifescience Center Open Innovation research – The Bayer Scientific Magazine Inventive Talent Otto Bayer Medal Products Product Areas Service Areas Information for Patients Beware of Counterfeits Report an Adverse Side-Effect Products from A to Z Sustainability Strategy Focus Issues Management and Governance Supplier Management Employees Product Stewardship Safety Environmental Protection Social Commitment Report Ratings, Rankings and Awards Media News Biographies Speeches Photos TV Footage Publications Videos Social Media Apps Events Background Information E-Cards Media Contact Investors Bayer Group Stock Bonds Reports Annual Stockholders’ Meeting 2016 Events Ad-hoc Publications News Handouts Downloads Service Career Why Bayer Working at Bayer How to join us Video Center Contact us Magazine close ×